Signaling pathways
-
BA8294 5-Amino-8-hydroxyquinolineSummary: 5-Amino-8-hydroxyquinoline (5A8HQ) is a potential anticancer candidate active molecule with favorable proteasome inhibitory activity. - BA8295 Enzyme-IN-1Summary: Enzyme-IN-1 is a peptide-based inhibitor of N-terminal nucleophilic reagent (Ntn) hydrolase.
-
BA8296 BC-23Summary: BC-23 (NSC45382) is a proteasome inhibitor. - BA8297 LU-002iSummary: LU-002i is a subunit-selective protease β2c and β2i inhibitor.
- BA8298 Ac-ANW-AMCSummary: Ac-ANW-AMC is a fluorescent substrate for the immunoproteasome.
- BA8299 Suc-Gly-Gly-Phe-pNA
- BA8300 FiVe1Summary: FiVe1 is a potent (VIM; intermediate fiber and mesenchymal marker) inhibitor.
- BA8301 NPD10084Summary: NPD10084 is a pyruvate kinase inhibitor that inhibits non-glycolytic signaling in cancer cells.
- BA8302 EtavopivatSummary: Etavopivat is a potent, selective, orally active erythrocyte pyruvate kinase activator.
- BA8303 TEPC466Summary: TEPC466 is a novel TEPP-46-based aggregation-induced emission (AIE) probe.